Mana Capital Acquisition Corp. (MAAQ) Shareholders Approve Cardio Diagnostics Deal
Mana Capital (NASDAQ:MAAQ) announced this morning that its shareholders approved its combination with biopharmaceutical firm Cardio Diagnostics in a special meeting held yesterday.
The press release did not disclose redemption amounts, but MAAQ traded below its trust value of $10 throughout its redemption deadline October 21, and closed yesterday at a low of $5.99. ...READ MORE
